Cullinan Associates’s Arvinas ARVN Stock Holding History

Cullinan Associates’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,000	Closed	-$248K	–	232
2024 Q1	$248K	Buy	+6,000	New	+$262K	0.01%	230
2023 Q3	–	Sell	-13,700	Closed	-$340K	–	243
2023 Q2	$340K	Hold	13,700	–	–	0.02%	214
2023 Q1	$374K	Hold	13,700	–	–	0.02%	206
2022 Q4	$469K	Hold	13,700	–	–	0.03%	208
2022 Q3	$610K	Hold	13,700	–	–	0.04%	168
2022 Q2	$577K	Sell	13,700 -4,600	-25%	-$231K	0.04%	170
2022 Q1	$1.23M	Hold	18,300	–	–	0.06%	138
2021 Q4	$1.5M	Hold	18,300	–	–	0.08%	131
2021 Q3	$1.5M	Sell	18,300 -17,200	-48%	-$1.52M	0.08%	128
2021 Q2	$2.73M	Hold	35,500	–	–	0.15%	110
2021 Q1	$2.35M	Hold	35,500	–	–	0.14%	110
2020 Q4	$3.02M	Buy	+35,500	New	+$1.22M	0.18%	100

Other funds holding ARVN

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Cullinan Associates's ARVN Position: Q2 2024 in Review

Cullinan Associates sold out of Arvinas (ARVN) in Q2 2024, closing a stake of 6,000 shares — an estimated $248K sold.

Cullinan Associates first reported a position in ARVN in Q4 2020 and held it in 12 quarters. The position peaked at $3.02M in Q4 2020. 207 funds tracked by Wall St. Rank hold ARVN as of Q2 2024.

Cullinan Associates reported no remaining Arvinas position as of Q2 2024 after selling out during the quarter.
Cullinan Associates sold 6,000 Arvinas shares in Q2 2024, an estimated $248K.
Cullinan Associates first reported a position in Arvinas in Q4 2020 and held it in 12 quarters.
Cullinan Associates's Arvinas position peaked at $3.02M in Q4 2020.
207 funds tracked by Wall St. Rank held Arvinas as of Q2 2024.

Based on Cullinan Associates's 13F filing for Q2 2024, filed 10 Jul 2024.